ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.4385
0.03%
Brent Oil
84.535
-0.19%
Bitcoin
65,157.10
0.29%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) Noticias

IVVD Invivyd Inc

1.40
-0.07 (-4.76%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Invivyd Inc IVVD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.07 -4.76% 1.40 15:47:40
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.47 1.40 1.47 1.40 1.47
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202406:07EDGAR2Form 8-K - Current report
14/6/202406:01GLOBEInvivyd Announces Antiviral Activity of VYD222 (pemivibart)..
06/6/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/6/202415:01GLOBEInvivyd to Participate at the Jefferies Global Healthcare..
31/5/202406:12EDGAR2Form 8-K - Current report
31/5/202406:05GLOBEInvivyd Announces General Alignment with U.S. FDA on a..
31/5/202406:00GLOBEInvivyd Announces the Appointment of Timothy Lee as Chief..
29/5/202406:00GLOBEInvivyd to Present Data at 2024 American Society of Clinical..
23/5/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202417:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202415:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/5/202406:06EDGAR2Form 8-K - Current report
22/5/202406:00GLOBEInvivyd Elects Two New Independent Members to its Board of..
16/5/202415:11EDGAR2Form 144 - Report of proposed sale of securities
13/5/202415:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
09/5/202415:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202415:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:08EDGAR2Form 8-K - Current report
09/5/202415:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
07/5/202406:38EDGAR2Form 8-K - Current report
07/5/202406:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
02/5/202416:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
30/4/202406:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
15/4/202406:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
12/4/202406:30GLOBEInvivyd Announces CEO Transition
04/4/202415:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
28/3/202406:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
22/3/202414:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
22/3/202414:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
12/2/202415:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202415:47EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202415:01EDGAR2Form 8-K - Current report
05/2/202415:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
26/1/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202406:12EDGAR2Form 8-K - Current report
03/1/202406:06EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
22/12/202315:53EDGAR2Form 8-K - Current report
22/12/202315:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202306:16EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
IVVD
Invivyd
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados